These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4393817)

  • 1. Effects of reserpine and desipramine on the uptake and subcellular distribution of 5-hydroxytryptamine in rabbit brain stem after intravenous administration of 5-hydroxytryptophan.
    Segawa T
    Jpn J Pharmacol; 1970 Mar; 20(1):87-91. PubMed ID: 4393817
    [No Abstract]   [Full Text] [Related]  

  • 2. The influences of drugs on the uptake of 5-hydroxytryptamine by nerve-ending particles of rabbit brain stem.
    Segawa T; Kuruma I
    J Pharm Pharmacol; 1968 Apr; 20(4):320-2. PubMed ID: 4384615
    [No Abstract]   [Full Text] [Related]  

  • 3. Uptake and storage mechanism of 5-hydroxytryptamine in rabbit brain stem and effect of reserpine.
    Takatsuka K; Segawa T; Takagi H
    Jpn J Pharmacol; 1971 Feb; 21(1):57-67. PubMed ID: 4403263
    [No Abstract]   [Full Text] [Related]  

  • 4. Influences of intraventricularly administered 5-hydroxytryptamine on normal and amine-depleted rabbit: subcellular distribution of 5-hydroxytryptamine in the brain stem, and animal behaviour.
    Segawa T; Fujisawa T
    Biochem Pharmacol; 1972 May; 21(9):1357-67. PubMed ID: 4261028
    [No Abstract]   [Full Text] [Related]  

  • 5. The influences of drugs on the uptake of 5-hydroxytryptamine by synaptic vesicles of rabbit brain stem.
    Segawa T; Kuruma I; Takatsuka K; Takagi H
    J Pharm Pharmacol; 1968 Oct; 20(10):800-1. PubMed ID: 4386752
    [No Abstract]   [Full Text] [Related]  

  • 6. 5-Hydroxytryptophan reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
    Boggan WO; Seiden LS
    Physiol Behav; 1973 Jan; 10(1):9-12. PubMed ID: 4540511
    [No Abstract]   [Full Text] [Related]  

  • 7. 5-hydroxytryptamine uptake by rat brain in vitro.
    Blackburn KJ; French PC; Merrills RJ
    Life Sci; 1967 Aug; 6(15):1653-63. PubMed ID: 5299290
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective protection of serotonin stores against the action of reserpine by -methyl-5-hydroxytryptpohan pretreatment.
    Lahti RA; Platz PA
    Biochem Pharmacol; 1969 Oct; 18(10):2363-9. PubMed ID: 4397869
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of growth conditions on serotonin content of Tetrahymena pyriformis.
    Brizzi G; Blum JJ
    J Protozool; 1970 Nov; 17(4):553-5. PubMed ID: 5313492
    [No Abstract]   [Full Text] [Related]  

  • 10. Synergism of imipramine and desmethylimipramine with reserpine in the frog. Interaction with 5-hydroxytryptophan and 2-bromolysergid diethylamide (BOL-148).
    Lapin IP; Osipova SV; Uskova NV; Stabrovski EM
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):37-49. PubMed ID: 5303117
    [No Abstract]   [Full Text] [Related]  

  • 11. Subcellular distribution of 5-hydroxytryptamine in rat brain during development: effect of drugs and fasting.
    Tissari AH; Raunu EM
    J Neurochem; 1975 Jun; 24(6):1143-50. PubMed ID: 1079237
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective protection of 5-hydroxytryptamine stores against the action of reserpine by treatment with 5-hydroxytryptophan.
    Carlsson A
    J Pharm Pharmacol; 1967 Nov; 19(11):783-4. PubMed ID: 4383709
    [No Abstract]   [Full Text] [Related]  

  • 13. [Contribution to norepinephrine and serotonin metabolism in the rat brain following stress conditions].
    Rüther E; Ackenheil M; Matussek N
    Arzneimittelforschung; 1966 Feb; 16(2):261-3. PubMed ID: 5299190
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetics of audiogenic seizures. 3. Time response relationships between drug administration and seizure susceptibility.
    Schlesinger K; Boggan WO; Freedman DX
    Life Sci I; 1970 Jul; 9(13):721-9. PubMed ID: 4394568
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary and gastrointestinal excretion of metabolites of labelled 5-hydroxytryptamine and 5-hydroxytryptophan.
    Airaksinen MM; Mattila K
    Acta Pharmacol Toxicol (Copenh); 1967; 25(4):473-82. PubMed ID: 4384076
    [No Abstract]   [Full Text] [Related]  

  • 16. Action of probenecid on the central nervous system of the rabbit. II. Potentiation of 5-hydroxytryptophan-induced hyperthermia and suppression of this effect by a decarboxylase inhibitor (Ro4-4602).
    Gardey-Levassort C; Olive G; Lechat P
    Pharmacology; 1974; 11(5):267-77. PubMed ID: 4546714
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-induced changes of 5-hydroxyindoles in central nervous system in the rats.
    Davila D; Palaić D; Rabadija M; Supek Z
    Acta Med Iugosl; 1973; 27(3):261-9. PubMed ID: 4541730
    [No Abstract]   [Full Text] [Related]  

  • 18. Functional aspects of 5-hydroxytryptamine turnover in the central nervous system.
    Modigh K
    Acta Physiol Scand Suppl; 1974; 403():1-56. PubMed ID: 4275711
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and uptake of 5-hydroxytryptamine by the myenteric plexus of the guinea-pig ileum. A histochemical study.
    Robinson RG; Gershon MD
    J Pharmacol Exp Ther; 1971 Aug; 178(2):311-24. PubMed ID: 4398295
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperthermia and elevated brain 5-hydroxytryptamine of rabbits in response to tryptophan and 5-hydroxytryptophan infusion.
    Weber LJ; Angell LA
    Biochem Pharmacol; 1967 Dec; 16(12):2451-4. PubMed ID: 5299746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.